Lv1
30 积分 2025-05-12 加入
A novel TREM1/DAP12-based multiple chain CAR-T cell targets PTK7 in ovarian cancer therapy
1天前
待确认
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
17天前
已完结
Harnessing eukaryotic retroelement proteins for transgene insertion into human safe-harbor loci
3个月前
已完结
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors
3个月前
已完结
Progress in the development of cytokine armoured CAR T cells
4个月前
已完结
In vivo site-specific engineering to reprogram T cells
4个月前
已完结
Single cell characterization and anti-tumor efficacy of single & multi-armored CAR Ts against CLDN18.2
5个月前
已关闭
mRNA lipid nanoparticle formulation, characterization and evaluation
5个月前
已完结
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
5个月前
已完结
Abstract 3129: Fibroblast activation protein directed CAR T cells engineered in situ using targeted lipid nanoparticles inhibit progression of pancreatic ductal adenocarcinoma
6个月前
已关闭
皖公网安备34019202002308
